John Bencich insider trades: Achieve Life Sciences (ACHV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | ACHV | ↑ Buy | 10,000 | $4.58 | $46K | Direct | Mar 6, 2024 (2d) |
| May 30, 2023 | ACHV | ↑ Buy | 5,000 | $5.50 | $28K | Direct | Jun 1, 2023 (2d) |
| May 27, 2021 | ACHV | ↑ Buy | 6,000 | $7.00 | $42K | Direct | May 27, 2021 (0d) |
| Aug 19, 2016 | OGXI | ↓ Sell | 1,380 | $0.57 | $787 | Direct | Aug 23, 2016 (4d) |
| Mar 15, 2016 | OGXI | ↓ Sell | 834 | $0.83 | $692 | Direct | Mar 16, 2016 (1d) |
| Aug 18, 2015 | OGXI | ↓ Sell | 1,427 | $2.76 | $4K | Direct | Aug 20, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ACHV insiders
Open-market trades in the last 12 months
About John Bencich's insider trades
John Bencich is CEO at Achieve Life Sciences (ACHV). Since Aug 18, 2015, John has reported 3 open-market purchases worth $115K and 3 sales worth $5K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (17 filings), option exercises (14 filings), shares withheld for taxes (11 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACHV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.